Table 2. Proportion of Individuals Eligible for Statin Therapy and Its Clinical Performance With Varying Risk Thresholds Using the New European-SCORE2 Model and Class I Recommendation.

10-y SCORE2 threshold, %	Overall			Women			Men
	Statin eligibility, %	Sensitivity, %	Specificity, %	Statin eligibility, %	Sensitivity, %	Specificity, %	Statin eligibility, %	Sensitivity, %	Specificity, %
All ages
20	0	0	100	0	0	100	0	0	100
15	1	1	99	0	0	100	1	3	99
10	5	13	93	1	3	99	10	20	91
7.50	12	31	88	4	10	96	24	46	77
5	31	57	69	17	34	83	48	73	53
4	42	69	58	27	47	74	61	83	40
3	56	81	45	39	64	61	75	92	25
2	72	90	28	57	78	44	91	97	10
1	90	97	10	83	94	18	99	99	1
Age 40-49 y
20	0	0	100	0	0	100	0	0	100
15	0	0	100	0	0	100	0	0	100
10	0	1	100	0	0	100	1	3	99
7.50	1	5	99	0	1	100	2	10	97
5	5	15	95	1	5	99	12	24	89
4	10	27	90	2	11	98	21	42	79
3	20	43	80	5	22	95	41	63	60
2	40	64	60	15	38	84	74	89	27
1	72	87	28	57	76	43	98	99	20
Age 50-69 y
20	0	0	99	0	0	100	0	0	100
15	0	2	99	0	0	100	2	3	99
10	7	16	93	1	3	98	13	24	86
7.50	20	36	81	7	12	93	35	52	66
5	46	66	56	27	41	72	68	82	34
4	60	77	41	42	57	57	82	91	19
3	75	88	26	60	76	39	93	97	8
2	89	95	12	80	90	19	98	99	2
1	99	99	2	98	99	2	99	99	1

Abbreviation: SCORE, Systematic Coronary Risk Evaluation.